| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |